Dyslipidaemia in polycystic ovarian syndrome: Different groups, different aetiologies?

Human Reproduction

Volumn 11, Issue 9, 1996, Pages 1848-1853

  Meirow, Dror ^a   Raz, Itamar ^a   Yossepowitch, Ofer ^a   Brzezinski, Amnon ^a   Rosler, Ariel ^a   Schenker, Joseph G ^a   Berry, Elliot M ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Androgens; DHEA S; Hyperinsulinaemia; Plasma lipids; Polycystic ovarian syndrome

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PRASTERONE SULFATE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY BUILD; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; ENDOCRINOLOGY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029821798     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019505     Document Type: Article

References (37)

1. Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-359.
2. Ardaens, Y., Robert, Y., Lemaitre, L., Fossati, P. and Dewailly, D. (1991) Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil. Steril., 55, 1062-1068.
3. Barbieri, R.L., Smith, S. and Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril., 50, 197-212.
4. Barrett-Connor, E., Khaw, K.-T. and Yen, S.S.C. (1986) A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med., 316, 1519-1524.
5. Bonadonna, R.C. and DeFronzo, R.A. (1992) Glucose metabolism in obesity and type II diabetes. In Bjorntorp, P. and Brodoff, B.N. (eds). Obesity. J.B.Lippincot Co., Philadelphia, PA, USA, pp. 474-501.
6. Buffington, C.K., Givens, J.R. and Kitabohi, A.E. (1991) Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes, 40, 663-670.
7. Burghen, G.A., Givens, J.R. and Kitbachi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 50, 113-116.
8. Conway, J.M., Norris, K.H. and Bodwell, C.E. (1984) A new approach for the estimation of body composition: infrared interactance. Am. J. Clin. Nutr., 40, 1123-1130.
9. Dunaif, A., Green, G., Futterweit, W. and Dobrjansky, A. (1990) Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 70, 699-704.
10. Eldar-Geva, T., Hurwitz, A., Vecsei, P. et al. (1990) Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N. Engl. J. Med., 323, 855-863.
11. Elia, M., Parkinson, S.A. and Diaz, E. (1990) Evaluation of near infrared interactance as a method for predicting body composition. Eur. J. Clin. Nutr., 44, 113-121.
12. Franks, S., Kiddy, D. and Sharp, P. (1989) Obesity and polycystic ovary syndrome. Ann. N.Y. Acad. Sci., 626, 201-206.
13. Friedwald, W., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
14. Goldberg, R.B., Rabin, D., Alexander, A.N., Doelle, G.C. and Getz, G.S. (1985) Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoprotein A-1 and B. J. Clin. Endocrinol. Metab., 60, 203-207.
15. Goldzieher, J.W. and Axelrod, L.R. (1963) Clinical and biochemical features of polycystic ovarian disease. Fertil. Steril., 14, 631-645.
16. Hoffman, D.L., Klove, K. and Lobo, R.A. (1984) The prevalence and the significance of the elevated dehydroandrosterone sulfate in anovulatory women. Fertil. Steril., 42, 76-81.
17. Kiddy, D.S., Sharp, P.S., White, D.M. et al. (1990) Differences in clinical endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol., 32, 213-220.
18. Laatikainen, T.J., Apter, D.L., Paavonen, J.A. and Wahlstrom, T.R. (1980) Steroids in ovarian and peripheral venous blood in polycystic ovarian disease. Clin. Endocrinol., 13, 125-134.
19. Lapidus, L., Bengtsson, C., Larsson, B. et al. (1984) Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J., 289, 1257-1261.
20. Leszczynski, D.E., Schafer, R.M., Perkins, E.G., Jerrell, J.P. and Kummerow, F.A. (1989) Esterification of dehydroepiandrosterone by human plasma HDL3. Biochim. Biophys. Acta, 1014, 90-97.
21. Lithell, H., Nilliu, S.J., Bergh, T. and Selinus, I. (1987) Metabolic profile in obese women with the polycystic ovary syndrome. Int. J. Obesity, 11, 1-8.
22. Mattson, L.-A., Cullberg, G., Hamberger, L., Samsioe and Silfverstolpe, G. (1984) Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil. Steril., 42, 579-584.
23. McKeigue, P.M., Pierpoint, T., Ferrie, J.E. and Marmot, M.G. (1992) Relationship of glucose intolerance and hyperinsulinemia to body fat pattern in South Asia and Europe. Diabetologia, 35, 785-791.
24. Meirow, D., Yossipowitch, O., Rosler, A. et al. (1995) Insulin resistant and non-resistant polycystic ovary syndrome represent two separate clinical and endocrinological subgroups. Hum. Reprod., 10, 1951-1956.
25. Mitchell, L.E., Sprecher, D.L., Borecki, I.B., Rice, T. and Laskanewski, P.M. (1994) Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation, 89, 89-93.
26. Mortola, J.F. and Yen, S.S.C. (1990) The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J. Clin. Endocrinol. Metab., 71, 696-704.
27. Nader, S. (1991) Polycystic ovary syndrome and the androgen insulin connection. Am. J. Obstet. Gynecol., 165, 346-348.
28. Nestler, J.E., Clore, J.N. and Blackard, W.G. (1992) Dehydroepiandrosterone: the 'missing link' between hyperinsulinemia and atherosclerosis. FASEB J., 6, 3073-3075.
29. Pasquali, R., Casimirri, F., Venturoli, S. et al. (1983) Insulin resistance in patients with polycystic ovaries; its relationship to body weight and androgen levels. Acta Endocrinol., 104, 110-116.
30. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
31. Sowers, J.R. (1992) Insulin resistance, hyperinsulinemia, dyslipidemia, hyperlipidemia and accelerated atherosclerosis. J. Clin. Pharmacol., 32, 529-535.
32. Stuart, C.A., Prince, M.J., Peters, E. and Meyers, W.J. (1987) Hyperinsulinemia and hyperandrogenism: in vivo response to insulin infusion. Obstet. Gynecol., 69, 921-925.
33. Wild, R.A. (1991) Lipid metabolism and hyperandrogenism. Clin. Obstet. Gynecol., 34, 797-871.
34. Wild, R.A. and Bartholomew, M.J. (1988) The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am. J. Obstet. Gynecol., 159, 423-427.
35. Wild, R.A., Painter, P.C., Coulson, P.B., Caruth, K.B. and Ranney, G.B. (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 61, 946-951.
36. Yen, S.C.C. (1980) The polycystic ovary syndrome. Clin. Endocrinol., 12, 177-207.
37. Young, M.H., Jeng, C.Y., Sheu, W.H.H. et al. (1993) Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am. J. Cardiol., 72, 458-460.